⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7422071 | 1.00 | — | — | |
| SCHEMBL190463 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL204916 | 0.98 | EGLN1 (0.59) | — | |
| Bromide SCHEMBL7324484 | 0.98 | EGLN1 (0.59) | — | |
| Acetic Acid SCHEMBL28021124 | 0.92 | EGLN1 (0.53) | — | |
| Acetic Acid SCHEMBL28021125 | 0.92 | EGLN1 (0.53) | — | |
| SCHEMBL11448834 | 0.88 | EGLN1 (0.50) | — | |
| SCHEMBL18439017 | 0.82 | EGLN1 (0.44) | — | |
| SCHEMBL18439015 | 0.82 | EGLN1 (0.44) | — | |
| SCHEMBL13804343 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 626 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026088246-A1 | METHOD FOR PRODUCING LOW-MOLECULAR-WEIGHT COMPOUND | ＮＴＴ株式会社 | 2026-04-30 | — | — | WO | claimed |
| CN-117530366-A | Antibacterial composition and application thereof | 航天神舟生物科技集团有限公司 | 2024-02-09 | — | — | CN | claimed |
| CN-117388421-A | Method for identifying forage grass rhizosphere secretion and differential metabolite thereof based on non-targeted metabonomics | 中国农业大学 | 2024-01-12 | — | — | CN | claimed |
| US-20210080466-A1 | MARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER | BPGBIO, INC. | 2021-03-18 | — | — | US | claimed |
| WO-2020264379-A1 | MARKERS FOR THE DIAGNOSIS OF PROSTATE CANCER | BERG LLC (US) | 2020-12-30 | — | — | WO | claimed |
| CN-111511757-A | Polymeric agonists of mu opioid receptors | 细胞凝胶制药有限责任公司 | 2020-08-07 | — | — | CN | claimed |
| CN-111165662-A | Feed additive, application thereof and feed with strong antibacterial activity | 航天神舟生物科技集团有限公司 | 2020-05-19 | — | — | CN | claimed |
| EP-3154568-A1 | NON-CANONICAL INSULINS AND THEIR USES | California Institute of Technology (US) | 2017-04-19 | — | — | EP | claimed |
| WO-2017021378-A1 | PROCESS FOR THE SYNTHESIS OF PROTECTED 4-KETO-PROLINE | PROCOS S.P.A. (IT) | 2017-02-09 | — | — | WO | claimed |
| CN-106349237-A | Method for preparing hydrobromic acid teneligliptin | 南通普悦生物医药有限公司 | 2017-01-25 | — | — | CN | claimed |
| CN-1926102-B | Process for the preparation of N-protected 4-ketoproline derivatives | DEGUSSA | 2011-01-05 | — | — | CN | claimed |
| WO-2010088527-A2 | PEPTIDES AND NANOPARTICLES FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONS | MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) | 2010-08-05 | — | — | WO | claimed |
| US-20070185336-A1 | Process for preparing n-protected 4-ketoproline derivatives | DEGUSSA AG (DE) | 2007-08-09 | — | — | US | claimed |
| CN-1926102-A | Process for the preparation of N-protected 4-ketoproline derivatives | DEGUSSA (DE) | 2007-03-07 | — | — | CN | claimed |
| US-7015306-B2 | Labeled neurotensin derivatives | BIOSYNTHEMA, INC. (US) | 2006-03-21 | — | — | US | claimed |
| US-20050191240-A1 | Peptide analogs of neurotensin resistant to enzymatic degradation and retain high binding affinity for neurotensin receptors; metal chelating group on one end; replacing Arg8 with Gly(PipAm) ((N-amidinopiperidinyl)glycine) for example; useful for diagnostic and therapeutic purposes | ADVANCED ACCELERATOR APPLICATIONS USA, INC. | 2005-09-01 | — | — | US | claimed |
| EP-1194444-A2 | LABELED NEUROTENSIN DERIVATIVES WITH IMPROVED RESISTANCE TO ENZYMATIC DEGRADATION | BioSynthema Inc. (US) | 2002-04-10 | — | — | EP | claimed |
| US-6262269-B1 | 4-Substituted-quinoline derivatives and 4-substituted-quinoline combinatorial libraries | TREGA BIOSCIENCES, INC. | 2001-07-17 | — | — | US | claimed |
| WO-2000078796-A2 | LABELED NEUROTENSIN DERIVATIVES WITH IMPROVED RESISTANCE TO ENZYMATIC DEGRADATION | MALLINCKRODT INC. (US) | 2000-12-28 | — | — | WO | claimed |
| US-5631385-A | Method for the preparation of N-substituted 4-ketoproline derivatives | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1997-05-20 | — | — | US | claimed |